Related Experiment Video
Updated: Aug 30, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
An alternative splice form of Mdm2 induces p53-independent cell growth and tumorigenesis
Heather A Steinman1, Ezra Burstein, Christopher Lengner
1Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.
Abstract:
The Mdm2 gene is amplified in approximately one-third of human sarcomas and overexpressed in a variety of other human cancers. Mdm2 functions as an oncoprotein, in part, by acting as a negative regulator of the p53 tumor suppressor protein. Multiple spliced forms of Mdm2 transcripts have been observed in human tumors; however, the contribution of these variant transcripts to tumorigenesis is unknown. In this report, we isolate alternative splice forms of Mdm2 transcripts from sarcomas that spontaneously arise in Mdm2-overexpressing mice, including Mdm2-b, the splice form most commonly observed in human cancers. Transduction of Mdm2-b into a variety of cell types reveals that Mdm2-b promotes p53-independent cell growth, inhibits apoptosis, and up-regulates the RelA subunit of NFkappaB. Furthermore, expression of Mdm2-b induces tumor formation in transgenic mice. These results identify a p53-independent role for Mdm2 and determine that an alternate spliced form of Mdm2 can contribute to formation of cancer via a p53-independent mechanism. These findings also provide a rationale for the poorer prognosis of those patients presenting with tumors harboring multiple Mdm2 transcripts.
Insights
This study reveals that the Mdm2-b splice form promotes cancer by driving p53-independent cell growth and inhibiting apoptosis. This finding explains why tumors with multiple Mdm2 transcripts often have a poorer prognosis.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The Mdm2 gene is frequently amplified and overexpressed in human cancers, particularly sarcomas.
- Mdm2 acts as an oncoprotein by inhibiting the p53 tumor suppressor.
- The role of Mdm2 alternative splice forms in cancer development remains unclear.
Purpose of the Study:
- To investigate the functional significance of Mdm2 alternative splice forms in tumorigenesis.
- To characterize the oncogenic potential of the Mdm2-b splice variant.
- To explore the p53-independent mechanisms by which Mdm2 contributes to cancer.
Main Methods:
- Isolation of Mdm2 alternative splice forms from Mdm2-overexpressing mouse sarcomas.
- Transduction of Mdm2-b into various cell types to assess its functional effects.
- Tumorigenesis studies in transgenic mice expressing Mdm2-b.
Main Results:
- Mdm2-b was identified as a common splice form in human cancers and isolated from mouse sarcomas.
- Mdm2-b expression promoted p53-independent cell proliferation and inhibited apoptosis.
- Mdm2-b up-regulated the RelA subunit of NF-kappaB and induced tumor formation in mice.
Conclusions:
- Mdm2 possesses oncogenic functions that are independent of p53.
- The Mdm2-b splice variant contributes to cancer development through p53-independent pathways.
- The presence of multiple Mdm2 transcripts correlates with a poorer patient prognosis, likely due to these alternative splice forms.
Related Concept Videos
Abnormal Proliferation
RNA Splicing
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Negative Regulator Molecules
Induced Pluripotent Stem Cells
Somatic cells are...

